Medidata Celebrates World Heart Day
Together, let’s solve the impossible for Cardiovascular Disease
Helping in the fight against Cardiovascular Disease
Cardiovascular disease (CVD) is the world’s number one killer, causing over 18.6 million deaths per year and affecting over 520 million people worldwide. Medidata’s cloud-based platform enables clinical trials to run smoother, faster, and safer for patients in today’s complex world of precision medicine and has the trial experience, technology and expertise to help Cardiovascular trials.
Glen de Vries: Making the World Heart Healthy
Hear from Glen de Vries, Co-founder of Medidata, a Dassault Systems Company, in support of World Heart Day and Medidata’s on-going commitment to help find treatments and cures for those suffering with cardiovascular disease.
The Adaptable Study, The Largest Decentralized Cardiovascular Trial to Date
For over half a century, millions of Americans living with heart disease have relied on a daily dose of aspirin to help prevent a heart attack or stroke. The large-scale ADAPTABLE study used Medidata solutions to manage patients virtually.